Matches in Wikidata for { <http://www.wikidata.org/entity/Q94982257> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94982257 description "clinical trial" @default.
- Q94982257 description "ensayo clínico" @default.
- Q94982257 description "ensayu clínicu" @default.
- Q94982257 description "klinisch onderzoek" @default.
- Q94982257 description "клінічне випробування" @default.
- Q94982257 description "临床试验" @default.
- Q94982257 name "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 name "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 type Item @default.
- Q94982257 label "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 label "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 prefLabel "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 prefLabel "Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 P1050 Q94982257-BE07BE6B-C143-473F-A9D5-D15FC2EB6827 @default.
- Q94982257 P1132 Q94982257-22D86A5A-0EE9-4939-8916-118B595E9B7E @default.
- Q94982257 P1476 Q94982257-383216EF-A58D-4171-B35B-BE934CA4564A @default.
- Q94982257 P17 Q94982257-9A133D6A-82A4-4981-9FFA-8E8900AB9478 @default.
- Q94982257 P1813 Q94982257-93FA3300-9D9E-42C1-A862-DD1A40CA5F5B @default.
- Q94982257 P2899 Q94982257-AC605EC0-72F6-4FB3-AAB8-960258EB4338 @default.
- Q94982257 P3098 Q94982257-C571B2AF-D383-4C77-85F6-F410123C5DA9 @default.
- Q94982257 P31 Q94982257-8F7945EF-0D79-49DB-A22D-20068835FAE1 @default.
- Q94982257 P4844 Q94982257-6C469E12-0864-4C96-A60E-7B1C7ED85C6B @default.
- Q94982257 P580 Q94982257-D212BF6F-7703-45A6-B682-188FD62A9F0F @default.
- Q94982257 P582 Q94982257-D9004D84-4DA5-4D15-8AE9-C8F9AA1FEE80 @default.
- Q94982257 P6099 Q94982257-7DC3A9D7-46EF-4490-9D06-10B6D829D5F7 @default.
- Q94982257 P6099 Q94982257-E1C054A1-F871-4E94-836C-99FF3C40A759 @default.
- Q94982257 P8005 Q94982257-586CE6B9-6067-491C-907B-9B67A07F6228 @default.
- Q94982257 P8363 Q94982257-BF78EBCC-BE0B-425E-ABE8-DD98E83297D8 @default.
- Q94982257 P921 Q94982257-4499450E-A445-4CEC-A85D-25C2F80252F1 @default.
- Q94982257 P1050 Q3433884 @default.
- Q94982257 P1132 "+26" @default.
- Q94982257 P1476 "TROPHAMET, a Phase I/II Trial of Avelumab and METhotrexate in Low-risk Gestational TROPHoblastic Neoplasias as First Line Treatment" @default.
- Q94982257 P17 Q142 @default.
- Q94982257 P1813 "TROPHAMET" @default.
- Q94982257 P2899 "+18" @default.
- Q94982257 P3098 "NCT04396223" @default.
- Q94982257 P31 Q30612 @default.
- Q94982257 P4844 Q422232 @default.
- Q94982257 P580 "2020-02-12T00:00:00Z" @default.
- Q94982257 P582 "2023-06-12T00:00:00Z" @default.
- Q94982257 P6099 Q42824440 @default.
- Q94982257 P6099 Q5452194 @default.
- Q94982257 P8005 Q76649708 @default.
- Q94982257 P8363 Q78089383 @default.
- Q94982257 P921 Q422232 @default.